These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17555397)

  • 1. Second-line therapy for esophageal cancer.
    Martin MG; Govindan R; Morgensztern D
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):871-6. PubMed ID: 17555397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy after second-line chemotherapy for patients with advanced or metastatic breast cancer].
    Ogasawara Y; Doihara H; Takahashi M; Kawasaki K; Taira N
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1713-6. PubMed ID: 18931574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced esophageal cancer.
    Kelsen D
    Cancer; 1982 Dec; 50(11 Suppl):2576-81. PubMed ID: 6182976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatment for oesophageal cancer.
    van Meerten E; van der Gaast A
    Eur J Cancer; 2005 Mar; 41(5):664-72. PubMed ID: 15763640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of chemotherapy and chemo-radiotherapy in patients with metastatic esophageal cancer].
    Mitsuhashi T; Miyazaki T; Sakimoto T; Kubo N; Ishiguro T; Okada N; Yokoyama M; Ishibashi K; Matsuki M; Takahashi T; Ishida H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):1999-2001. PubMed ID: 19106503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-line therapy in bladder cancer.
    Bachner M; De Santis M
    Curr Opin Urol; 2009 Sep; 19(5):533-9. PubMed ID: 19550334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal cancer: a critical evaluation of systemic second-line therapy.
    Thallinger CM; Raderer M; Hejna M
    J Clin Oncol; 2011 Dec; 29(35):4709-14. PubMed ID: 22067408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of salvage treatment in advanced colorectal cancer.
    Capdevila J; Ramos FJ; Macarulla T; Elez E; Tabernero J
    Crit Rev Oncol Hematol; 2009 Jul; 71(1):53-61. PubMed ID: 18977669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting.
    Gallagher DJ; Milowsky MI; Bajorin DF
    Cancer; 2008 Sep; 113(6):1284-93. PubMed ID: 18629841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line chemotherapy for advanced hormone-refractory prostate cancer.
    Garmey EG; Sartor O; Halabi S; Vogelzang NJ
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):118-22, 127-32. PubMed ID: 18347563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent therapy in the palliative treatment of metastatic colorectal cancer.
    Wadhawan A; Stephens R; Adams R
    Expert Rev Anticancer Ther; 2009 Jan; 9(1):125-34. PubMed ID: 19105712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG-ps) in patients receiving palliative chemotherapy for gastroesophageal cancer.
    Crumley AB; Stuart RC; McKernan M; McDonald AC; McMillan DC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e325-9. PubMed ID: 17645468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma.
    Tachimori Y; Kanamori N; Uemura N; Hokamura N; Igaki H; Kato H
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):49-54. PubMed ID: 19154902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
    Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal cancer: current and emerging therapy modalities.
    Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
    Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of second-line chemotherapy for advanced gastric adenocarcinoma.
    Wilson D; Hiller L; Geh JI
    Clin Oncol (R Coll Radiol); 2005 Apr; 17(2):81-90. PubMed ID: 15830569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
    Berhoune M; Banu E; Scotte F; Prognon P; Oudard S; Bonan B
    Ann Pharmacother; 2008 Nov; 42(11):1640-52. PubMed ID: 18957625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
    Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance treatment in metastatic breast cancer.
    Sánchez-Muñoz A; Pérez-Ruiz E; Ribelles N; Márquez A; Alba E
    Expert Rev Anticancer Ther; 2008 Dec; 8(12):1907-12. PubMed ID: 19046111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.